A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy

Despite improvements in the management of liver cancer, the survival rate for patients with hepatocellular carcinoma (HCC) remains dismal. The survival benefit of systemic chemotherapy for the treatment of liver cancer is only marginal. Although the reasons for treatment failure are multifactorial,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Pharmacol
Egile Nagusiak: Gillet, Jean-Pierre, Andersen, Jesper B., Madigan, James P., Varma, Sudhir, Bagni, Rachel K., Powell, Katie, Burgan, William E., Wu, Chung-Pu, Calcagno, Anna Maria, Ambudkar, Suresh V., Thorgeirsson, Snorri S., Gottesman, Michael M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The American Society for Pharmacology and Experimental Therapeutics 2016
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4727122/
https://ncbi.nlm.nih.gov/pubmed/26668215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.101360
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak